Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
autoimmune disorders
biotech
boston
boston blog main
boston top stories
clinical trials
complement system
deals
fda
generalized myasthenia gravis
immune-mediated necrotizing myopathy
life sciences
national blog main
ra pharmaceuticals
rare disease drugs
ucb
zilucoplan
What
alternative
2
×
drug
pharmaceuticals
2
×
adamis
administration
allergy
approved
autoimmune
candidate
cheaper
clear
compete
corporation
cost
criticized
deal
directly
disease
epipen
expensive
fda
food
heavily
it’ll
lead
manufacturer
medication
medicine
medicines
mylan’s
new
pharma
potential
ra
shot
stakes
territory
that’s
ucb
unaffordable
Language
unset
Current search:
pharmaceuticals
×
alternative
×
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@theverge.com
6 years ago
Cheaper alternative to EpiPen allergy shot approved by FDA
